Company ProfilePremium

Shandong Hualu-Hengsheng Chemical Co., Ltd.

Company Profile Analysis

Ticker: 600426.SS山东华鲁恒升化工股份有限公司

ESOMAR 23 Corporate BadgeISO Certifications Badge
Shandong Hualu-Hengsheng Chemical Co., Ltd. - Company showcase

Year Founded & Workforce

2000

Shandong Hualu-Hengsheng Chemical Co., Ltd. logo

Shandong Hualu-Hengsheng Chemical Co., Ltd. Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Shandong Hualu-Hengsheng Chemical Co., Ltd. Overview

Hualu-Hengsheng is China's benchmark low-cost coal-to-chemicals producer. It runs a flexible multi-product syngas platform ("一头多线、柔性联产") built on clean-coal gasification. From one feedstock it produces more than 40 products across four segments: (1) new-energy and new-materials chemicals (DMC, oxalic/dibasic acids, 2-ethylhexanol, adipic acid, caprolactam, nylon-6, BDO/NMP); (2) nitrogen fertilizer (urea); (3) organic amines (DMF and methylamines); and (4) acetic acid and derivatives. The company describes itself as the world's largest DMC supplier and the world's largest DMF producer [AR25-S via NBD-0326]. Since 2021 it has moved from a single site in Dezhou (Shandong) to a "twin carrier" ("双航母") model, adding a second integrated base in Jingzhou (Hubei) that is 70% owned. Its competitive edge is structural cost leadership. That edge widens when crude oil is expensive relative to coal, as in H1 2026. The main pressures on it are domestic overcapacity, carbon constraints on coal chemicals, and product-price cyclicality.


Company's own description (FY2025 / H1 2026 reports, paraphrased)

The company describes itself as a "comprehensive multi-product co-production chemical enterprise" (多业联产的综合型化工企业) [AR25-S; H1-26]. Its licensed scope covers:

  • basic chemical raw materials

  • chemical and specialty chemical products

  • fertilizer production and sales

  • synthetic materials

  • hazardous-chemical production and trading

  • power generation and supply

  • heat and steam supply

  • coal and coal-product sales, added to the articles in March 2025 [AR24-S]

The four reporting product lines are new-energy/new-materials related products, chemical fertilizers, organic amines, and acetic acid and derivatives [H1-26].

The operating model has three pillars, as described in [H1-26]:

Production: intrinsic safety, environmental protection, high quality, continuous optimisation and lean management. Clean-coal gasification is used to build a "flexible multi-co-production operating mode".

Procurement: "transparent full-process procurement" with strategic supplier relationships, a strict supplier-access regime and source-level purchasing.

Marketing: "cooperation creates value; co-opetition creates win-win", focused on quality, integrity, brand and service.

Independent characterisation

SupplierPrepayment (CNY Mn)Share of prepayments
Shaanxi Coal Transportation & Marketing Group Jianhong Investment257.237.7%
Shaanxi Future Energy Chemical77.8—
Yankuang Energy (Ordos)54.5—
ProductEnd uses
DMCLithium-battery electrolyte solvent; polycarbonate feedstock; developer solutions; pharmaceuticals; precursor to EMC/DEC electrolyte solvents
Dibasic (oxalic) acidNew energy, rare-earth separation, pharmaceuticals
2-Ethylhexanol (octanol)Plasticiser raw material and solvent
Adipic acidNylon-66, polyurethane, 1,6-hexanediol, TPU, powder coatings
CaprolactamNylon-6 high-speed spinning and conventional chips, MC nylon
Nylon-6 chipsFilament yarn, engineering plastics, industrial yarn, BOPA film, staple fibre
UreaAgriculture and industrial uses
DMFPolar solvent for chemicals, pharmaceuticals, electronics and PU leather
Acetic acidAcetate esters, PTA, vinyl acetate, chloroacetic acid, glycine

Business model. Hualu-Hengsheng is a pure product business: it sells commodity and semi-specialty chemicals. Service, subscription and licensing revenue is essentially nil. Small "other business" income comes from by-products, steam sales and leasing; it was RMB 186.1M in H1 2026, or 1.1% of revenue [H1-26].

How value is created.

  • Coal is gasified into syngas (CO + H₂). Syngas becomes ammonia, methanol and CO.

  • These platform molecules are steered toward whichever downstream chain has the best margin at the time: urea, DMF/methylamines, acetic acid, ethylene glycol / oxalate chain, DMC/EMC, or oxo-alcohols.

  • Purchased benzene and propylene feed the adipic acid / caprolactam / nylon-6 and 2-ethylhexanol chains.

  • The main input costs are thermal and raw coal (sourced from Shaanxi and Inner Mongolia suppliers), benzene and propylene.

  • In FY2025 the purchase price ranges were raw coal RMB 600–810/t, benzene RMB 4,560–7,230/t and propylene RMB 5,150–6,470/t [OPS25].

Value-chain position. The company sits in the mid-stream as a basic and intermediate chemicals converter. Upstream, it buys rather than owns coal. Its five largest prepayment counterparties at 30 Jun 2026 were:

Source: [H1-26]. Downstream, its products go into a wide range of industrial and agricultural chains.

Customer types and end-markets.

Source: [H1-26].

Customer concentration.

  • In FY2021 the top five customers were 10.17% of sales and the top five suppliers were 33.41% of purchases [CS-2203].

  • Exports were 4.6% of H1 2026 revenue (RMB 795.4M) [H1-26].

  • The largest receivable counterparties at 30 Jun 2026 were overseas polyurethane and chemical buyers, which fits the DMF/adipic acid export profile:

    • KIMPUR UK Ltd: 27.2% of receivables

    • JMD Chemicals: 19.8%

    • KIMTEKS Poliuretan (Turkey): 10.2%

    • Methyl Co Ltd: 6.5%

    • Merino Industries: 6.1%

Sales terms. Domestic sales are largely cash or bank-acceptance before delivery. Receivables were only RMB 59.1M against H1 2026 revenue of RMB 17.16bn. Bank and commercial acceptance notes and e-credit instruments carried in "receivables financing" were RMB 2.68bn [H1-26].

Strategy

Stated strategic themes (FY2025 AR, as paraphrased in [NBD-0326] and [H1-26])

Core strategic framework. The company plans to use the national "de-capacity / anti-involution" drive, which is accelerating the exit of obsolete capacity, to advance four themes:

  • refreshing existing assets (存量焕新)

  • raising efficiency (效能提优)

  • coupling value chains (链条耦合)

  • upgrading products (产品升级)

The goals are to "optimise platforms, extend chains and expand clusters" and to build a model of technology-driven cost reduction, higher-end products and supply-chain synergy.

Growth pole. New energy and new materials is named as the core growth pole. Specific links include:

  • NMP for lithium-battery solvents

  • dibasic acid for new energy and rare-earth separation

  • DMC/EMC for electrolytes

Geographic model. "One body, two wings" and "twin aircraft carriers" (Dezhou plus Jingzhou).

Digital and AI. The company reports 100% digital-technology penetration in manufacturing and full automatic-control coverage. It was selected for the national first batch of excellence-level smart factories and is "actively exploring AI applications" [NBD-0326; H1-26].

H1 2026 operating priorities [H1-26]:

  • deepen market penetration and seize fertilizer exports

  • diversify marketing to escape homogeneous competition

  • dig further into cost reductions

  • accelerate project construction to cement the twin-carrier layout

Strategic initiatives (last 24 months)

InitiativeDateScope / targetStatus (latest)Source
Gasification Platform Upgrade (德州)Announced Aug 2025Budget RMB 3,039.05M; 18-month construction; scale-efficiency and cost-floor uplift63.16% complete; RMB 1,324M in CIP at 30 Jun 2026[H1-26]; [KY-0826]
200kt/yr monobasic acid project2024–25Budget RMB 815.67M99.55% complete (H1-26)[H1-26]
Melamine-resin monomer materials project2024–25Budget RMB 733.78M52.38% complete[H1-26]
Additional 200kt dibasic acid (proposed)2,026Capacity expansionProposed[KY-0826]
Jingzhou BDO/NMP/PBAT integrationCommissioned 23 Aug 2025200/160/30ktRamping[HA-1125]
200kt dibasic (oxalic) acidCommissioned 9 Sep 2025New-energy and rare-earth chainsRamping (main driver of H1-26 volume)[HA-1125]; [SMW-0926]
Amide raw-material optimisation upgradeCompleted 2025Caprolactam-chain cost reductionComplete[CW-0826]
Jingzhou capital increaseApproved 5 Dec 2025RMB 2.0bn pro rata (company RMB 1.4bn) to de-lever the subsidiaryRMB 1.0bn first tranche done[H1-26]
Small technical upgradesOngoingRMB 1,498M in CIP at 30 Jun 2026Ongoing[H1-26]
Shareholder-return programme2025–26Buyback (7.85M shares cancelled); semi-annual dividends; 3-for-10 bonus issueExecuted[H1-26]
Structured-deposit cash managementRenewed Mar 2026Up to RMB 2.0bnRMB 100M outstanding at 30 Jun 2026[AR25-S]; [H1-26]
ESG governanceFY2025ESG Leading Group chaired by the Chairman; ESG report prepared to SSE Guideline No.14In place[AR25-S]

Guidance and medium-term targets

MetricCompany targetActual outcomeSource
FY2025 revenue budgetRMB 34.7bnRMB 30.97bn (missed by 10.8%)[AR24-S]
FY2026 revenue budgetRMB 33.5bn (+8.2% vs FY2025)H1 2026 at 51% of budget[AR25-S]; [H1-26]
PayoutCash payout ≥30% in practice (FY2024 32.6%, FY2025 31.9%); three-year cumulative cash payout 100.2% of average NP—[AR25-S]
Medium-term financial targets (margins, ROE)———

The company warns that forward-looking statements are not commitments [AR25-S].

Products & Services

Capacities are design capacities per [H1-26] unless stated otherwise. Prices are ex-tax ranges from [OPS24]/[OPS25] or average/median prices from [CW-0826] and [KY-0826]. The company sells at market prices and discloses no list-price model. Price-list and product-specification sheets are not publicly disclosed.

New-energy & new-materials related products

ProductDescription & usesCapacityStart / latest expansionFY2024 price range (MYR Bn/t)FY2025 price range (MYR Bn/t)2026 data point
Dimethyl carbonate (DMC)Li-ion electrolyte solvent; PC (non-phosgene) feedstock; developer; pharma; precursor to EMC/DEC. World's largest supplier per the company.600ktExpanded through 2022–233,010–5,7502,920–5,800H1-26 median RMB 4,430/t, +8.85% YoY [CW-0826]
Ethyl methyl carbonate (EMC) / diethyl carbonate (DEC)Electrolyte co-solvents. Electronic grades developed in 2022.300kt EMC unit commissioned around Mar–Apr 2023 [CLS-2303]2,023———
Dibasic acid (oxalic acid, 二元酸/草酸)New energy (e.g. battery-material precursors), rare-earth separation, pharma500kt200kt line started 9 Sep 2025——Q2-26 oxalic acid avg RMB 4,382/t, +21.3% QoQ [KY-0826]
2-Ethylhexanol (isooctanol, 异辛醇)Plasticiser (DOTP/DOP) raw material and solvent200kt—6,650–12,0305,130–7,080Q2-26 octanol avg RMB 8,431/t [KY-0826]
Adipic acidNylon-66 salt, PU polyols, 1,6-HDO, TPU, powder coatings526.6kt200kt Dezhou unit 20246,800–9,3005,300–8,400H1-26 median RMB 7,875/t, +14.96% [CW-0826]
Caprolactam (CPL)Nylon-6 high-speed and conventional spinning chips; MC nylon300ktAmide & nylon project around 2021–22; amide raw-material upgrade 20259,200–12,3907,120–9,960Q2-26 avg RMB 12,077–12,563/t [GS-0826; KY-0826]
Nylon-6 (PA6) chipsFilament yarn, engineering plastics, industrial yarn, BOPA film, staple200kt2,0229,910–13,9807,610–10,360—
1,4-Butanediol (BDO)PBT, PU, THF/PTMEG, GBL→NMP feedstock200kt (Jingzhou)Started 23 Aug 2025——Q2-26 avg RMB 8,139/t [KY-0826]
N-methyl-pyrrolidone (NMP)Li-ion cathode-slurry solvent160kt (Jingzhou)Started 23 Aug 2025———
PBATBiodegradable polyester30kt (Jingzhou)Started 23 Aug 2025———
Ethylene glycol (coal-based) †Polyester feedstockNot disclosed in H1-26 product listLegacy (2010s)———

Chemical fertilizers

ProductDescriptionCapacityNotesFY2024 price rangeFY2025 price range2026 data point
UreaNitrogen fertilizer for agriculture; industrial uses (AdBlue/DEF, resins)3,070ktIncludes Jingzhou phase-2 520kt (2024)1,510–2,5701,390–2,060H1-26 median RMB 1,660/t, -5.41% YoY; Q2-26 market avg RMB 1,869/t [CW-0826; GS-0826]
Ammonia (merchant), ammonium sulphate (by-product)Fertilizer and industrial—Ammonium sulphate is a CPL by-product (480kt planned in 2019)——Q2-26 synthetic ammonia avg RMB 2,731/t [KY-0826]

Organic amines

ProductDescriptionCapacityNotes2026 data point
DMF (dimethylformamide)High-polarity solvent for PU leather, pharma, electronics, acrylic fibre480ktWorld's largest producer per companyQ2-26 avg RMB 4,700/t, flat QoQ; "supply ample, margins compressed" [GS-0826]
Methylamines (mono-, di-, tri-)Intermediates for DMF, pesticides, pharma, water treatment—Largely captive into DMF—

Acetic acid & derivatives

ProductDescriptionCapacityFY2024 price rangeFY2025 price range2026 data point
Glacial acetic acidMethanol carbonylation; used in acetate esters, PTA, VAM, chloroacetic acid, glycine1,500kt2,350–3,2302,010–2,630H1-26 median RMB 3,255/t, +37.05% YoY [CW-0826]
Acetic anhydrideCellulose acetate, pharma————

Other products and utilities

ProductStatusSource
Melamine (legacy)—2019–20 broker notes
Formic acid200kt planned with the 2019 nylon project2019–20 broker notes
Melamine-resin monomer materialsProject under construction: budget RMB 733.78M, 52.38% complete at 30 Jun 2026[H1-26]
200kt/yr "monobasic acid" (一元酸) project99.55% complete at 30 Jun 2026; budget RMB 815.67M[H1-26]
Steam / powerSteam sold to the related-party Dezhou Thermal Power; RMB 28.6M in H1 2026[H1-26]

Financial Narrative

All figures are in RMB millions unless the row label says otherwise. Sources by year:

  • FY2021: [CS-2203]

  • FY2022: [AR24-S] 3-year table and [CLS-2303]

  • FY2023–FY2025: [AR24-S], [AR25-S]

  • Expense and balance-sheet detail FY2024–25: [GS-0826] and [KY-0826], which reproduce reported statements

Income statement

Revenue CAGR FY2021–FY2025 (derived): +3.8% per year. Attributable NP CAGR FY2021–FY2025 (derived): -17.8% per year.

EPS comparability. Following the July 2026 3-for-10 bonus issue, brokers restate FY2025 EPS to RMB 1.21 and FY2024 to RMB 1.42 on the 2.75bn-share base [KY-0826]. Guosen still shows RMB 1.56 for FY2025 [GS-0826]. Readers should check which share base a source uses.

DPS detail.

Quarterly trajectory: notes and sources

Sources: [AR24-S]; [AR25-S]; Q1-26 from Tencent News; Q2-26 from [GS-0826]. Q2-26 OCF is derived as H1 RMB 2,692M minus Q1 RMB 891M.

Balance sheet

Notes on sources:

  • FY2024 current-portion figure is Guosen's "short-term borrowings & trading liabilities" line [GS-0826]. Kaiyuan shows short-term borrowings of zero for FY2024 [KY-0826].

  • FY2025 current portion of LT borrowings is from [H1-26] comparatives.

  • Working capital is per Stockstar's compilation of reported data.

Cash flow

Notes on sources:

  • Capex is from [KY-0826]. Guosen shows RMB 5,411M for FY2024 and RMB 3,655M for FY2025 [GS-0826]; the discrepancy reflects line definitions.

  • FY2025 buyback is treasury stock held for buyback at 31 Dec 2025. Cumulative buyback cost cancelled in May 2026 was RMB 200.1M [H1-26].

  • D&A is per [KY-0826].

  • H1 2026 cash flow [H1-26]: OCF RMB 2,692M (+15.5%), capex RMB 1,656M, derived FCF RMB 1,036M. Dividends paid in cash in H1 were only RMB 159.6M because the RMB 528.8M final dividend was paid in July.

Ratios

Notes on sources and methods:

  • ROIC: FY2021 from [CS-2203]; FY2024–25 from [KY-0826]. Guosen shows 10% and 8%.

  • ROA is derived as attributable NP divided by year-end assets.

  • Interest coverage is derived as (operating profit + finance cost) divided by finance cost.

  • Asset turnover is derived using average assets.

  • Receivable days are near zero because of cash and acceptance-note terms.

Commentary — trends, inflections, drivers

1. Cycle peak to trough and back (FY2021 → FY2025).

  • FY2021 was a super-cycle peak. Revenue doubled and NP quadrupled on strong urea, DMF and acetic acid prices, with gross margin at 35.5% and ROE at 38.5% [CS-2203].

  • From FY2022 to FY2023 prices normalised. Gross margin compressed to 28.9% and then below 20%. NP fell 51% across those two years.

  • FY2024 was a volume-led recovery. Jingzhou's ramp lifted revenue +25.6% to a record RMB 34.2bn, but NP grew only 9.1% because price spreads kept narrowing [AR24-S].

  • FY2025 brought price deflation across nearly every product. Revenue fell 9.5%, but gross margin actually improved about 0.4pp to 19.2%: falling coal (raw coal RMB 600–810/t vs RMB 747–940/t in FY2024) and benzene costs offset product-price declines, and cost of sales fell 10.0% [OPS25; NBD-0326].

2. Inflection in H1 2026.

  • Attributable NP rose 50% on revenue growth of only 8.9%, because cost of sales rose just 0.8% [H1-26].

  • Q2-26 gross margin reached 25.8% [GS-0826].

  • The company attributes the improvement to "anti-involution" (反内卷) supply discipline and to the geopolitical oil shock, which the H1 report describes as the US–Israel–Iran war. Higher oil raised prices for oil-based competitors' products while Hualu's coal-based costs rose less: coal median +9.4%, against acetic acid +37% and adipic acid +15% [H1-26; CW-0826].

3. R&D step-change.

  • R&D expense rose 34% to RMB 886M in FY2025 [NBD-0326].

  • It rose a further 95% to RMB 684M expensed in H1 2026, or RMB 733M including RMB 48M capitalised [H1-26].

  • H1 R&D intensity was 3.99%, up 1.76pp [CW-0826]. Materials made up RMB 514M of the expensed amount, which points to large pilot and trial-run programmes [H1-26].

4. Balance-sheet discipline.

  • Leverage remains low: liabilities/assets 28.5% at FY2025 and net debt/EBITDA about 1.1x. This was maintained despite RMB 5.1bn of capex in FY2024 and RMB 3.65bn in FY2025.

  • The company has issued no bonds. Bank debt is mostly guaranteed by the controlling shareholder, which began charging a guarantee fee from August 2026.

5. Cash conversion.

  • OCF has tracked or exceeded attributable NP in every year shown. In FY2025 OCF was 1.27x attributable NP, helped by D&A of about RMB 3.2bn.

  • Working capital turned from negative RMB 2.4bn (FY2023) to roughly zero (FY2025) as payables to equipment vendors were settled.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Group Entities

EntityRoleOwnershipKey data

Shandong Hualu-Hengsheng Chemical Co., Ltd. (parent)

Dezhou integrated base

Listed

H1 2026 parent revenue RMB 12,826M; parent NP RMB 1,906M

Hualu-Hengsheng (Jingzhou) Co., Ltd. (荆州恒升)

Second base, Jiangling, Hubei

70% direct. Minorities (30%): HK Hualu and Hualu Investment (related parties under Hualu Holdings).

Registered capital RMB 6,000M. H1 2026: total assets RMB 19,296M, net assets RMB 8,544M, revenue RMB 4,447M, operating profit RMB 751M, NP RMB 637M.

Segment (Company Label) Overview

Segment (company label)ContentsKey named productsDesign capacity (H1-26)

New-energy & new-materials related products (新能源新材料相关产品)

Electrolyte solvents and precursors, oxalate/dibasic acids, oxo-alcohols, nylon chain, BDO/NMP

DMC; dibasic acid; 2-EH (isooctanol); adipic acid; caprolactam; nylon-6

DMC 600kt; dibasic acid 500kt; 2-EH 200kt; adipic acid 526.6kt; caprolactam 300kt; nylon-6 200kt

Chemical fertilizers (化学肥料)

Nitrogen fertilizer

Urea

Urea 3,070kt

Organic amines (有机胺系列产品)

Amide solvents and methylamines

DMF (lead product); mono-, di- and tri-methylamine

DMF 480kt

Acetic acid & derivatives (醋酸及衍生品)

Carbonylation chain

Glacial acetic acid (lead); acetic anhydride

Acetic acid 1,500kt

Other products / by-products

Melamine, formic acid, ammonium sulphate, liquid ammonia, steam/power and other

——

“—” = not publicly disclosed.

Segment revenue (CNY Mn)

Segment revenue (CNY Mn)FY2023FY2024FY2025

New-energy & new-materials related products

—16,43315,557

Chemical fertilizers

—7,2977,306

Organic amines

—2,5112,361

Acetic acid & derivatives

—4,0703,387

Other products & by-products (derived residual)

—3,9153,388

Total revenue

27,26034,22630,969

Segment YoY growth (%)

Segment YoY growth (%)FY2024FY2025

New-energy & new-materials related products

—-5.3

Chemical fertilizers

—0.1

Organic amines

—-6.0

Acetic acid & derivatives

—-16.8

Total revenue

25.6-9.5

Segment share of total revenue (%)

Segment share of total revenue (%)FY2024FY2025

New-energy & new-materials related products

48.050.2

Chemical fertilizers

21.323.6

Organic amines

7.37.6

Acetic acid & derivatives

11.910.9

Other

11.410.9

Segment sales volume (kt)

Segment sales volume (kt)FY2024FY2025

New-energy & new-materials related products

2,5523,002

Chemical fertilizers

4,7125,752

Organic amines

587586

Acetic acid & derivatives

1,5501,562

H1 2026 Segment Details

H1 2026 segmentRevenueCostGross profit (derived)Gross margin % (derived)YoY revenue %Share of revenue %

New-energy & new-materials

9,329.37,614.01,715.418.4+22.4354.4

Chemical fertilizers

3,882.32,592.71,289.633.2+0.0822.6

Organic amines

1,155.5904.9250.621.7

≈0

6.7

Acetic acid & derivatives

1,877.81,191.8686.036.5+10.0810.9

Other products

731.5549.0182.524.9—4.3

By-products & other business

186.1174.012.26.5—1.1

Total

17162.5

13026.4

4136.1

24.1

+8.87

100

9m 2025 Details

9M 2025Revenue (CNY Mn)YoY %Sales volume (kt)Volume YoY %

New-energy & new-materials

11,556-6.172,163.4+13.84

Chemical fertilizers

5,826+11.014,332.9+35.45

Organic amines

1,769-5.55432.9+0.87

Acetic acid & derivatives

2,515-17.491,143.8+1.64

Income Statement and Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025

Revenue (CNY Mn)

26,63630,24527,26034,22630,969

Revenue growth (%)

103.113.5-9.925.6-9.5

Cost of sales (CNY Mn)

———27,82125,037

Gross profit (CNY Mn; FY21–22 derived from reported GM)

9,4538,753—6,4055,932

R&D expense (CNY Mn)

———661886

Operating profit (CNY Mn)

———5,0084,251

EBITDA (CNY Mn; broker-compiled from reported data)

———8,3158,010

Pre-tax profit (CNY Mn)

——4,2815,0154,262

Income tax (CNY Mn)

———836607

Net profit incl. minorities (CNY Mn)

———4,1783,656

Net profit attributable (CNY Mn)

7,2546,2893,5763,9033,315

Attributable NP ex non-recurring (CNY Mn)

7,2126,4173,7033,8703,288

EPS basic as reported (MYR Bn)

3.432.9651.6891.8411.563

EPS diluted as reported (MYR Bn)

—2.9651.6891.8411.563

Cash DPS declared for the fiscal year (MYR Bn, pre-2026 bonus issue)

0.80—0.600.600.50

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025

Gross margin (%)

35.4928.94—18.7119.15

Operating margin (%)

———14.6313.73

EBITDA margin (%)

———24.325.9

Net margin attributable (%)

27.2320.7913.1211.4010.71

Cash Flow History

Fiscal yearInterimFinalTotal cash

FY2023

——

RMB 1,273.99M (≈RMB 0.60/sh)

FY2024

RMB 0.30/sh

RMB 0.30/sh

RMB 1,273.26M

FY2025

RMB 0.25/sh

RMB 0.25/sh

RMB 1,058.46M (31.92% payout)

Financial Analysis

MetricQ1-24Q2-24Q3-24Q4-24Q1-25Q2-25Q3-25Q4-25Q1-26Q2-26

Revenue (CNY Mn)

7,9788,9978,2059,0467,7727,9927,7897,4168,3448,819

Attributable NP (CNY Mn)

1,0651,1598258547078628059421,1171,236

Operating cash flow (CNY Mn)

1,1311,7789831,0779301,4019678998911,801

Balance Sheet

MetricFY2021FY2022FY2023FY2024FY2025

Total assets (CNY Mn)

—35,00544,05146,65849,177

Cash & equivalents (CNY Mn)

———1,3982,085

Short-term borrowings (CNY Mn)

———0776

Current portion of LT debt (CNY Mn)

———1,1981,973

Long-term borrowings (CNY Mn)

———8,2248,139

Total interest-bearing debt (CNY Mn, derived)

———9,42210,888

Net debt (CNY Mn, derived)

———8,0248,803

Total liabilities (CNY Mn)

———13,83014,027

Equity attributable (CNY Mn)

—26,92328,89131,01833,080

Minority interests (CNY Mn)

———1,8102,070

Goodwill (CNY Mn)

00000

Intangible assets (CNY Mn)

———2,3672,857

Fixed assets (CNY Mn)

———30,05732,994

Net working capital (CNY Mn)

——-2,425-1,58424

Financial Analysis — Total assets

ItemCNY Mn

Total assets

51,694

Cash

3,171

Structured deposits

100

Short-term borrowings

567

Current portion of LT borrowings

2,431

Long-term borrowings

8,017 (of which RMB 7,487M guaranteed by the controlling shareholder)

Total interest-bearing debt (derived)

≈11,015

Net debt (derived)

≈7,744

Equity attributable

34,933

Minority interests

2,563

Construction in progress

3,438

Cash Flow

MetricFY2021FY2022FY2023FY2024FY2025

Operating cash flow (CNY Mn)

4,9066,9994,7154,9684,198

Capex (CNY Mn)

———5,0813,650

Free cash flow (CNY Mn, derived)

———-113548

Cash dividends declared for year (CNY Mn)

——1,2741,2731,058

Share buybacks executed (CNY Mn, approx.)

0000167

Depreciation & amortisation (CNY Mn)

———2,8003,226

Returns & Leverage Ratios (%) and Financial Ratios (x)

MetricFY2021FY2022FY2023FY2024FY2025

ROE weighted (%)

38.5325.5812.8113.0510.32

ROIC (%)

33.97——12.110.1

ROA (%)

—18.08.18.46.7

Current ratio (x)

———1.331.54

Debt to equity (x)

———0.300.33

Liabilities to assets (%)

———29.628.5

Net debt to EBITDA (x)

———0.961.10

Interest coverage (x)

———23.817.2

Asset turnover (x)

———0.750.65

Region revenue (CNY Mn)

Region revenue (CNY Mn)H1 2026Share of H1 2026 revenue (%)

Domestic (Mainland China)

16,36795.4

Overseas (export)

7954.6

Total

17,162100

Geographic Revenue

BaseH1 2025 revenue (CNY Mn)H1 2026 revenue (CNY Mn)YoY %H1 2026 NP (CNY Mn)NP YoY %

Jingzhou, Hubei (Central China)

4,1084,447+8.3637+17.7

Dezhou parent, Shandong (North China), standalone

12,01812,826+6.71,906+60.3

Share Price History

DateShare price (MYR Bn)Market cap (CNY Mn)Shares (M)BasisSource

29 Oct 2025

Not stated

—2,123

PE TTM 16.62x; PB 1.64x; PS 1.65x

Eastmoney / CS 29 Oct 2025

30 Mar 2026

37.1778,9192,123

Pre-bonus

[NBD-0326]

19 Aug 2026

20.9657,6392,750

Post-bonus

[GS-0826]

24 Aug 2026

20.0755,1912,750

Post-bonus

[KY-0826]

52-week range to 24 Aug 2026

44.10 / 17.88

——

Mixed adjustment basis (high likely pre-bonus)

[KY-0826]

Valuation Multiples

MultipleHualu-HengshengBasis

P/E TTM (x)

13.5

TTM attributable NP RMB 4,099M = FY25 3,315 − H1-25 1,569 + H1-26 2,353

P/E FY2026E (x)

11.0–12.2

Consensus of Kaiyuan, Guosen and Great Wall [KY-0826; GS-0826; CW-0826]

P/B MRQ (x)

1.58

Equity attributable RMB 34,933M at 30 Jun 2026

EV (CNY Mn)

≈65,600

Mcap + debt RMB 11,015M − cash & deposits RMB 3,271M + minorities RMB 2,563M

EV/Sales TTM (x)

2.03

TTM revenue RMB 32,367M

EV/EBITDA FY2025 (x)

≈8.2

EBITDA RMB 8,010M [KY-0826]. Broker figures: Guosen 7.7x; Kaiyuan 8.3x.

Peer Comparison

PeerFY26E PE (x)PB (x)

Baofeng Energy

10.13.1

Luxi Chemical

15.41.2

Hubei Yihua

17.82.2

Hualu-Hengsheng

12.21.7

Analyst Ratings & Targets

BrokerRatingFY2026E NP (CNY Mn)FY2027E NP (CNY Mn)FY2028E NP (CNY Mn)FY2026E revenue (CNY Mn)

Guosen Securities

Outperform

4,7404,9585,23437,209

Kaiyuan Securities

Buy

5,0406,0096,82735,813

Great Wall Securities

Buy

4,7705,5786,41836,401

Dividend (MYR Bn per share as declared)

Dividend (MYR Bn per share as declared)FY2021FY2023FY2024FY2025

Total cash DPS declared (MYR Bn)

0.800.600.600.50

Cash payout ratio (%)

—35.632.631.9

Capital Programmes

ProgrammeSharesCostStatus

April 2025 programme

7,845,881

≈RMB 200M

Executed and cancelled 6 May 2026

Bucket Details

BucketCNY MnNotes

≤1 year

≈3,004

Short-term borrowings RMB 567M + current portion RMB 2,431M + accrued interest RMB 6M

1 year

8,017

Long-term loans; RMB 7,487M guaranteed by Shandong Hualu-Hengsheng Group

Lease liabilities

≈51

Including current portion

Analyst Conclusions

Management guidance

ItemDetailSource
FY2026 revenue budgetRMB 33.5bn (+8.2%). H1 delivered RMB 17.16bn, or 51% of budget.[AR25-S]; [H1-26]
Qualitative guidanceSeize fertilizer exports, deepen strategic cooperation, push cost reductions, speed project construction, reinforce the "twin carrier" model[H1-26]
Earnings guidanceNo earnings guidance is given—

Consensus growth expectations

FY2026E: revenue RMB 35.8–37.2bn (+16–20%); attributable NP RMB 4.74–5.04bn (+43–52%) [GS-0826; KY-0826; CW-0826].

FY2027–28E: NP growth ranges from mid-single-digit (Guosen) to mid-teens (Kaiyuan, Great Wall).

Run-rate check: H1 2026 NP of RMB 2.35bn annualises to about RMB 4.7bn, consistent with the lower end of the consensus range.

Bull case

  1. Coal-vs-oil spread persistence. If crude stays elevated (WTI around USD 89 in early Oct 2026), oil-based competitors continue to set higher price floors. H1-26 already shows gross margin expanding to 24.1% from 18.0% a year earlier, with cost of sales up only 0.8% on revenue up 8.9% [H1-26].

  2. Volume plus cost-floor step-up. New-energy/new-materials volumes grew 16.8% in H1-26, led by oxalic acid. The RMB 3.04bn gasification upgrade, about 63% complete, should reach completion in 2027 and lower unit costs. Melamine-monomer and further dibasic-acid projects add optionality [H1-26; SMW-0926; KY-0826].

  3. Undemanding valuation with rising returns. The stock trades at about 13.5x TTM and about 1.6x book, against FY2026E ROE of about 13% [GS-0826]. Low leverage (≈28% liabilities/assets) and a growing dividend (FY2026 interim +35% equivalent) support yield and re-rating potential.

Bear case

  1. Overcapacity is structural, not cyclical. DMC utilisation is 54%, DMF 45%, and urea capacity exceeds demand by about 8Mt [NBD-0326]. The FY2025 revenue budget miss (RMB 30.97bn against RMB 34.7bn) shows how quickly volume gains are wiped out by pricing.

  2. Windfall reversal. The H1-26 earnings rebound rests on a geopolitical oil shock. Coal is already +27% YoY in Q2-26 [KY-0826]. A Middle East de-escalation could compress spreads just as new capacity ramps. The share-price slide of about 29% (adjusted) from March to August 2026 suggests the market already doubts sustainability.

  3. Rising structural costs and governance drag. The new guarantee fee to the controlling shareholder, the end of interest capitalisation (H1 finance costs +29.5%), R&D up 94.5%, possible loss of the 15% HNTE tax rate after Nov 2026, and future carbon-intensity limits all erode the cost moat at the margin [H1-26; SSE Aug 2026].

Catalysts and monitorables (next 12 months)

TimingCatalyst / monitorableWhat to watch
Late Oct 2026Q3 2026 resultsWhether Q3 NP holds above RMB 1.1bn amid higher coal costs; 9M run-rate vs RMB 4.7–5.0bn consensus
Q4 2026Payment of the RMB 0.26 interim dividendCash return execution
Around Nov 2026Parent HNTE certificate renewal15% vs 25% tax rate
OngoingBrent/WTI vs Chinese thermal-coal pricesKey spread driver
OngoingUrea export-quota policyFertilizer upside
OngoingOxalic acid / DMC / NMP pricingNew-energy chain economics
OngoingGasification upgrade progress (63% at H1-26)On-time completion around 2027
OngoingSecond RMB 1.0bn Jingzhou capital-increase trancheSubsidiary de-leveraging
OngoingNew project approvals (dibasic acid, melamine monomer)Capex intensity vs payout
OngoingGuarantee-fee quantumRelated-party cost
Ongoing15th FYP coal-chemical carbon benchmarksRetrofit capex risk
Mar 2027FY2026 annual reportFY2027 revenue budget; final dividend

Concluding analyst verdict

Hualu-Hengsheng remains the highest-quality operator in China's coal-chemicals complex. It can prove the claim through the trough. In FY2025, with nearly every product priced below the prior year and the industry openly describing itself as "involuted", the company still produced:

  • RMB 3.3bn of net profit

  • RMB 4.2bn of operating cash flow

  • a 19% gross margin, about 8 points above its closest product-overlap peer

The balance sheet has absorbed more than RMB 8.7bn of capex in two years without bond issuance. In the same period the company paid out more than its average annual earnings in dividends over three years and retired 7.85M shares.

The H1 2026 rebound (+50% NP) is real but has two sources. Part of it is structural: oxalic-acid and BDO/NMP volumes, cost discipline, and a second base now earning 14% net margins. Part of it is exogenous: an oil shock that widened the coal-route advantage. The market appears to price in mainly the exogenous part. Post-bonus, the shares trade around 13x trailing and 11–12x forward earnings at roughly 1.6x book, having de-rated about 29% from March despite accelerating profits.

The downside is cushioned by a demonstrated cost floor, a payout that has grown with each interim, and modest leverage. The upside depends on three things: oil staying firm, the gasification upgrade being delivered in 2027, and "anti-involution" policy actually removing marginal capacity.

The key swing factors to monitor are:

  • the Q3 2026 margin print against rising coal

  • HNTE tax renewal

  • the scale of the new guarantee fee

  • the 15th Five-Year carbon rules

The investment case is therefore constructive but not one-way. This is a best-in-class cyclical, not a structural grower. Position size should reflect sensitivity to the oil–coal spread rather than to management execution, which remains consistently strong.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRole (as disclosed)NotesSource

Chang Huaichun (常怀春)

Chairman; legal representative; Strategy Committee convener

Also legal representative of the controlling shareholder, Shandong Hualu-Hengsheng Group (2026). Held 100,000 restricted shares (unlocked).

[H1-26]; [AR25-S]

Qi Shaoqing (祁少卿)

Director; Strategy Committee member

Related director (recuses on related-party votes). 80,000 restricted shares.

[H1-26]; [AR24-S]

Gao Jinghong (高景宏)

Director; principal in charge of accounting (CFO-equivalent); Nomination Committee

80,000 restricted shares

[H1-26]

Yu Fuhong (于富红)

Director; Strategy Committee

Also legal representative of the related party Dezhou Thermal Power

[AR25-S]

Zhang Chengyong (张成勇)

Director; Audit Committee

Related director

[AR24-S]; [AR25-S]

Sun Yiqian (孙一倩)

Director

Related director; 23,334 restricted shares

[H1-26]

Guo Shaohui (郭绍辉)

Independent director; Nomination Committee convener

—

[AR24-S]; [AR25-S]

Wu Fei (吴非)

Independent director; Remuneration Committee convener

—

[AR24-S]

Huang Rong (黄蓉)

Independent director; Audit Committee convener

—

[AR24-S]

Li Xingang (李新刚)

Independent director

Strategy and Nomination Committees

[AR24-S]

Ma Jianchun (马建春)

Director (Remuneration Committee member per Mar 2025 composition)

—

[AR24-S]

Board of Directors — Zhuang Guangshan

NameTitleRestricted shares

Zhuang Guangshan (庄光山)

Senior executive; board director until 2025

80,000

Yang Zhaoying (杨召营)

Senior executive

80,000

Zhang Jie (张杰)

Senior executive

80,000

Gao Wenjun (高文军)

Board secretary

33,334

Zhang Hucheng (张虎城)

Head of accounting department

—

Directors' Remuneration

CommitteeMembers

Strategy

Chang (convener), Guo, Li, Qi, Yu

Remuneration & Appraisal

Wu (convener), Ma, Guo

Nomination

Guo (convener), Li, Huang, Gao Jinghong, Zhuang

Audit

Huang (convener), Wu, Zhang Chengyong

Major Shareholders

#HolderShares%Change in H1 2026
1

Shandong Hualu-Hengsheng Group (with concert parties: Dezhou Thermal Power 41.90M, Hualu Investment 2.08M, Hualu Intl Business Center 0.32M)

681,061,37432.200
2

HKSCC (Northbound Stock Connect)

80,071,7843.79+44,816,349
3

NSSF Portfolio 106

53,193,9582.51-5,500,739
4

Zhongtai Xingyuan Value Flexible Allocation Fund

16,850,7970.80+2,821,429
5

Penghua CSI Chemical Sub-industry ETF

15,180,6170.72-2,603,318
6

NSSF Portfolio 103

13,000,0000.61-6,000,000
7

Basic Pension Fund Portfolio 807

12,771,9720.60-7,878,429
8

China Life – Traditional Product 005L-CT001

12,664,4540.60+1,719,512
9

Basic Pension Fund Portfolio 15022

12,590,2380.60+8,608,800
10

Harvest Fund – NSSF Portfolio 16042

11,785,7390.56-3,503,200

Competitive Landscape

Key Competitors

CompetitorTickerOverlapping segmentsVerified data pointRelative positioning vs Hualu-Hengsheng

Ningxia Baofeng Energy

600989.SH

Coal chemicals (olefins, coking); coal-to-chemicals cost peer

Mcap RMB 173.5bn; FY2025 EPS RMB 1.56; FY2026E PE 10.1x; PB 3.1x (19 Aug 2026) [GS-0826]

Larger and olefins-focused; higher market valuation

Luxi Chemical

000830.SZ

Urea, DMF, caprolactam/PA6, PC, formic acid

FY2025 revenue RMB 29,143M (-2.1%); NP RMB 907M (-55.3%); gross margin 10.97%; mcap RMB 22.6bn (Lanjinger 29 Apr 2026; [GS-0826])

Closest product-overlap peer (also Shandong). Hualu's FY2025 gross margin of 19.2% was about 8pp higher.

Hubei Yihua Chemical

000422.SZ

Urea, PVC, coal chemicals (Central China, close to Jingzhou)

Mcap RMB 13.7bn; FY2025 EPS RMB 0.75 [GS-0826]

Regional competitor for the Jingzhou base

Shanghai Huayi Group

600623.SH

Acetic acid, methanol, carbonylation

—

Major acetic acid producer (East China)

Jiangsu Sopo / Yankuang (Yankuang Lunan, Rongxin)

—

Acetic acid

—

Large acetic acid producers

Shida Shenghua (Shengtai)

603026.SH

DMC and electrolyte solvents

—

DMC/EMC competitor in the Li-ion solvent chain

Hualu's DMF peers (Zhejiang Jiangshan Chemical and others)

—

DMF

—

Hualu is the self-described global No.1

Huafon Chemical / Pingmei Shenma

002064.SZ / 600810.SH

Adipic acid; nylon-66/6

—

Large adipic acid producers

Hengyi / Highsun / Juhua (caprolactam players)

various

Caprolactam / PA6

—

Caprolactam capacity growth pressured CPL prices in FY2025

Henan Xinlianxin Chemical (Stanley Fertilizer)

1866.HK

Urea, DMF, methanol

—

Coal-based urea/DMF peer

Yuntianhua

600096.SH

Fertilizers (phosphate plus nitrogen)

—

Broad fertilizer peer

Wanhua Chemical

600309.SH

Petrochemicals, PU, new materials

FY2025 PU revenue RMB 75.06bn, petrochemicals RMB 84.20bn, fine chemicals & new materials RMB 33.19bn (Wanhua FY2025 operating data)

Much larger diversified chemicals benchmark; oil/LPG-based rather than coal-based

Peer Comparison FY2025

MetricHualu-Hengsheng (600426)Luxi Chemical (000830)Baofeng Energy (600989)Hubei Yihua (000422)

Revenue FY2025 (CNY Mn)

30,96929,143——

Revenue growth FY2025 (%)

-9.5-2.1——

Gross margin FY2025 (%)

19.210.97——

Attributable NP FY2025 (CNY Mn)

3,315907——

Net margin FY2025 (%)

10.73.1——

R&D intensity FY2025 (%)

2.9———

Market cap (CNY Mn, 19 Aug 2026)

57,63922,623173,50713,736

PE FY2026E (x)

12.215.410.117.8

PB MRQ (x)

1.71.23.12.2

Company Snapshot

$4,307.2M

Revenue

2000

Founded

SWOT Analysis

Strengths

  • Cost leadership through the trough. Gross margin held at 19.2% in FY2025 despite double-digit product-price declines, against Luxi Chemical's 10.97% [AR25-S; Lanjinger].
  • Global scale leadership in DMC (600kt) and DMF (480kt) [H1-26; NBD-0326].
  • Low leverage. Liabilities/assets were 28.5% at FY2025 and 27.5% at H1-26 (derived), with no bonds outstanding [KY-0826; H1-26].
  • Strong cash generation. OCF was RMB 4.2bn in FY2025 and RMB 2.69bn in H1-26 (+15.5%), and has exceeded attributable NP in every year shown [AR25-S; H1-26].
  • Disciplined shareholder returns. Three-year cumulative cash dividends of RMB 3.61bn equal 100.2% of average annual NP; the company also cancelled 7.85M buyback shares [AR25-S; H1-26].
  • Proven project execution. Two major units (BDO/NMP/PBAT and dibasic acid) started within 17 days of each other in Aug–Sep 2025 [HA-1125].
  • Second base delivering returns. Jingzhou earned RMB 637M NP on RMB 4.45bn revenue in H1-26, a 14.3% net margin [H1-26].

Weaknesses

  • Earnings cyclicality. NP fell from RMB 7.25bn (FY2021) to RMB 3.32bn (FY2025), and ROE from 38.5% to 10.3% [CS-2203; AR25-S].
  • Commodity product mix with little pricing power. DMC utilisation is 54% and DMF 45% industry-wide [NBD-0326].
  • Budget miss. FY2025 revenue of RMB 30.97bn came in 10.8% below the RMB 34.7bn budget [AR24-S; AR25-S].
  • Dependence on parent guarantees and related-party channels. RMB 7.49bn of LT loans are guaranteed by the controlling shareholder, now with a fee. The related-party cap rose to RMB 1,418M for FY2026 [H1-26; AR25-S].
  • Thin segment disclosure. No segment operating profit is reported, which limits external analysis [H1-26].
  • Rising finance costs as capitalisation ends. H1-26 finance costs rose 29.5% as completed projects stopped capitalising interest [H1-26].
  • Minimal export diversification. Exports were 4.6% of revenue, leaving the company exposed to the domestic oversupply cycle [H1-26].

Opportunities

  • High oil-to-coal spread. In H1-26 acetic acid rose 37% and adipic acid 15% YoY while coal rose 9% [CW-0826].
  • "Anti-involution" capacity exits favour large, efficient producers. The company explicitly targets this window [NBD-0326].
  • Battery-materials chain. NMP 160kt, DMC/EMC and oxalate tie into EV and energy-storage growth [NBD-0326].
  • Gasification upgrade. The RMB 3.04bn project, 63% complete, is expected to lower the cost floor by around 2027 [H1-26; KY-0826].
  • Fertilizer exports. Management prioritises them, and higher LC-backed export receivables point to growing export sales [H1-26].
  • New chains. The melamine-resin monomer project (RMB 734M) and a further 200kt dibasic acid project broaden the product slate [H1-26; KY-0826].

Threats

  • Persistent overcapacity. Urea effective capacity of 75.79Mt exceeds consumption of 67.60Mt, and new DMC units were still starting up at end-2025 [NBD-0326].
  • Coal-cost inflation. Q2-26 thermal coal was up 27% YoY [KY-0826].
  • Carbon regulation. Carbon caps on coal-chemical products under the 15th FYP may require costly retrofits [H1-26].
  • Geopolitical volatility. The H1 report flags unpredictable impacts of the US–Israel–Iran war on energy and fertilizer markets [H1-26]. A reversal in oil would compress the advantage.
  • Weak end-demand pass-through. The company notes higher raw-material prices without a matching rise in end consumption [H1-26].
  • Tax-incentive renewal risk. The parent's HNTE certificate (Nov 2023, 3-year validity) comes due around Nov 2026. Loss of the 15% rate would raise tax toward 25% [H1-26].

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
17 Apr 2025Board approves open-market buyback CSJ 27 Jun 2026First buyback; signals market-value management
29 Apr 2025FY2024 AGM [AR24-S]Approves RMB 0.30 final dividend, FY2025 revenue budget of RMB 34.7bn and the articles change adding coal sales
10 May 2025Buyback report published [H1-26]Buyback formally launched
Aug 2025Gasification Platform Upgrade announced (RMB 3.04bn) [KY-0826]; [H1-26]Largest new capex; aims to raise the profit floor
2–31 Aug 2025Planned maintenance shutdown of selected Dezhou units [HA-1125]Weighed on Q3-25 volumes
23 Aug 2025H1 2025 results: revenue RMB 15.76bn (-7.1%), NP RMB 1.57bn (-29.5%) Stockstar 24 Aug 2025Trough of the down-cycle
23 Aug 2025Jingzhou 200kt BDO / 160kt NMP / 30kt PBAT start-up [HA-1125]New-energy chain extension
9 Sep 2025200kt dibasic acid project start-up [HA-1125]Volume driver into 2026
29–30 Oct 2025Q3 2025 results: 9M revenue RMB 23.55bn (-6.5%), NP RMB 2.37bn (-22.1%); Q3 gross margin 18.38% [HA-1125]; EastmoneyQ3 NP RMB 805M; brokers called it ahead of expectations
5 Dec 2025RMB 2.0bn Jingzhou capital increase approved [H1-26]De-levers the subsidiary; commits the minority partners
2025 (year)Interim dividend RMB 0.25/share (RMB 529.4M) paid [AR25-S]First full year of semi-annual dividends at this scale
29 Jan 2026Restricted-share repurchase and cancellation (33,336 shares) [H1-26]Housekeeping
9 Mar 2026Third tranche of 2021 restricted shares deemed vested (3.45M shares) [H1-26]Incentive plan completes its first-grant cycle
27–30 Mar 2026FY2025 results; RMB 0.25 final dividend plus 3-for-10 bonus; FY2026 revenue budget RMB 33.5bn; auditor reappointed [AR25-S]; Stockstar 1 Apr 2026Q4-25 NP RMB 942M (+10.3% YoY) shows an inflection. Results were slightly below the ≈RMB 3.42bn consensus.
31 Mar 2026New RMB 1.0bn related-party sales framework with Shandong Hualu Group; FY2026 related-party cap raised to RMB 1,418M [AR25-S]Widens channels; higher related-party exposure
1 Apr 20263.45M restricted shares listed [H1-26]Small free-float addition
28 Apr 2026Q1 2026: revenue RMB 8.34bn (+7.4%), NP RMB 1.12bn (+58.0%); debt ratio 28.96% Tencent NewsEarnings recovery confirmed
6 May 2026Buyback results; 7,845,881 shares cancelled [H1-26]Share count falls to 2,115.3M
13–16 May 2026FY2025 / Q1 2026 results-and-dividend briefing; Shandong investor day CFI listingInvestor engagement
21 May 2026FY2025 AGM approves dividend, bonus issue and interim-dividend mandate [H1-26]—
27 Jun 2026Dividend and bonus totals adjusted for the share-count change: RMB 528.8M cash; 634.6M bonus shares CSJ 27 Jun 2026—
3–4 Jul 2026Controlling shareholder proposes a 2026 interim dividend CFI listingSignals a parent-company cash need and shareholder-return orientation
10 Jul 2026Bonus issue and dividend paid; shares rise to 2,749.9M CSJ 20 Aug 2026Price mechanically adjusted down
18 Aug 2026Board: H1 report; RMB 0.26 interim dividend; guarantee-fee related-party transaction with the controlling shareholder; articles amendment for registered capital; 2026 director and executive pay plan SSE announcements 20 Aug 2026Governance and cost item (guarantee fee)
20 Aug 2026H1 2026 results: revenue RMB 17.16bn (+8.9%), NP RMB 2.35bn (+50.0%); R&D +94.5% [H1-26]Strongest half since H1 2024
20–27 Aug 2026Broker updates: Guosen "Outperform" (FY26E NP RMB 4.74bn); Kaiyuan "Buy" but trims FY26E to RMB 5.04bn; Great Wall "Buy" (FY26E RMB 4.77bn) [GS-0826]; [KY-0826]; [CW-0826]Estimates converge on about RMB 4.7–5.0bn
3 Sep 2026Press coverage notes social-security funds held the stock for 55 consecutive quarters [SMW-0926]Ownership stability
14 Sep 20262026 First EGM; all resolutions passed (44.50% of voting shares present) SSE 2026-039Approves board items, including the related-party guarantee-fee matter
23 Sep 2026Scheduled unlock of 280,002 reserved-grant restricted shares [H1-26]Minor
Late Oct 2026 (expected)Q3 2026 report —Next earnings catalyst; not yet published at dossier date

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

4 charts
Income Statement: Revenue & Gross Profit: Revenue rose from CNY 26,636 Mn in FY2021 to CNY 30,969 Mn in FY2025.
Shandong Hualu-Hengsheng Chemical Co., Ltd. — Income Statement: Revenue & Gross Profit
Series (CNY Mn)FY2021FY2022FY2023FY2024FY2025
Revenue26,63630,24527,26034,22630,969
Cost of sales———27,82125,037
Gross profit9,4538,753—6,4055,932

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. Shandong Hualu-Hengsheng Chemical Co., Ltd., 2026 Semi-Annual Report (full text), 20 Aug 2026 — stockmc.xueqiu.com/202608/600426_20260820_4AI8.pdf: SSE/CNINFO summary static.cninfo.com.cn/finalpage/2026-08-20/1225481540.PDF
  2. FY2025 Annual Report Summary, Board 9-8 resolutions, dividend, auditor, related-party, structured-deposit, operating-data and ESG-summary announcements — China Securities Journal, 31 Mar 2026, epaper.cs.com.cn/zgzqb/images/2026-03/31/B049/zqB04931.pdf
  3. FY2024 Annual Report Summary, Board 9-4 resolutions, dividend, related-party and operating-data announcements — China Securities Journal, 29 Mar 2025, epaper.cs.com.cn/zgzqb/images/2025-03/29/B071/zqB07129.pdf
  4. Adjustment of FY2025 dividend/bonus totals (临2026-025) — epaper.cs.com.cn/zgzqb/images/2026-06/27/B064/zqB06427.pdf
  5. FY2025 dividend implementation (临2026-026) — pdf.dfcfw.com/pdf/H2_AN202607031826697549_1.pdf
  6. 2026 interim dividend plan (临2026-029) — static.cninfo.com.cn/finalpage/2026-08-20/1225481568.PDF
  7. Articles amendment / share-capital change — epaper.cs.com.cn/zgzqb/images/2026-08/20/B040/zqB04020.pdf
  8. Guarantee-fee related-party announcement — static.cninfo.com.cn/finalpage/2026-08-20/1225481558.PDF
  9. 2026 First EGM notice and resolutions — static.cninfo.com.cn/finalpage/2026-08-20/1225481565.PDF; static.cninfo.com.cn/finalpage/2026-09-15/1225563053.PDF
  10. Q1 2026 report coverage — paper.cnstock.com/html/2026-04/28/content_2207369.htm; news.qq.com/rain/a/20260428A02OZR00
  11. National Business Daily, FY2025 results analysis, 30 Mar 2026 — nbd.com.cn/articles/2026-03-30/4315868.html
  12. Securities Market Weekly, H1 2026 analysis, 3 Sep 2026 — static.weeklyonstock.com/26/0903/wd172039.html
  13. Guosen Securities results note, 20 Aug 2026 — pdf.dfcfw.com/pdf/H3_AP202608201828195474_1.pdf
  14. Kaiyuan Securities update, 24 Aug 2026 — pdf.dfcfw.com/pdf/H3_AP202608241828366008_1.pdf
  15. Great Wall Securities note (via Gelonghui), Aug 2026 — m.gelonghui.com/news/5298703
  16. Huaan Securities Q3 2025 note (via Stockstar), 13 Nov 2025 — stock.stockstar.com/JC2025111300018434.shtml
  17. Debon Securities FY2024 note (via Stockstar), 23 Apr 2025 — stock.stockstar.com/JC2025042400004135.shtml
  18. Stockstar FY2025 and H1 2025 results digests — stock.stockstar.com/RB2026040100005176.shtml; stock.stockstar.com/RB2025082400001103.shtml
  19. China Securities / Eastmoney Q3 2025 digest — finance.eastmoney.com/a/202510293549043361.html
  20. China Securities Net FY2021 results, 29 Mar 2022 — cs.com.cn/xinpi/cis/202203/t20220329_6255079.html
  21. Cailian Press FY2022 results, 30 Mar 2023 — cls.cn/detail/1308551
  22. Lanjinger, Luxi Chemical FY2025 results, 29 Apr 2026 — lanjinger.com/d/1777442511254909074
  23. Historical broker notes (2019–2020) hosted on img3.gelonghui.com (project budgets and historical R&D)
  24. CFI announcement index for 600426 — quote.cfi.cn/ggqw/1207/600426.html

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.